Category: Latest News
-
Tesla’s India Debut Falls Short with Around 600 Orders – Bloomberg
Tesla Inc (NASDAQ:TSLA) has seen a modest response following its long-anticipated launch in India, Bloomberg reported Tuesday, with the electric car maker receiving just over 600 orders since mid-July. According to sources cited by Bloomberg, the figure falls below Tesla’s own projections and represents only a small portion of the company’s global sales this year,…
-
Global Stocks Extend Gains, Japan and Europe Outperform
The MSCI All Country World Index advanced 2.4% in August, supported by strong corporate earnings, growing expectations of interest rate cuts, and sustained enthusiasm for artificial intelligence, according to Bank of America. Since hitting a cyclical bottom on April 8, global equities have surged 28.1%. Japan has led the rebound, posting a 6.9% gain in…
-
SPAC News From The Last Seven Days
The Last Week’s Deals Alchemy Investments Acquisition Corp 1 (NASDAQ:ALCY) revealed plans to acquire Cartiga, LLC, technology-driven asset management platform that specializes in investing in legal claims and law firms. The transaction values Cartiga at about $540 million. The companies did not disclose a closing timeline. Inflection Point Acquisition Corp. III (NASDAQ:IPCX) reported a deal…
-
Dow Jones, S&P, Nasdaq, Five market themes to watch in the coming week
Markets enter a shortened trading week under the weight of ongoing legal disputes over U.S. tariffs, alongside anticipation for key economic data releases and corporate earnings. Investors will monitor employment figures, a series of business activity indicators, and the Federal Reserve’s “Beige Book,” while Broadcom and Salesforce are among the companies reporting results. Ongoing legal…
-
Wegovy Shows Superior Cardiovascular Safety Compared to Tirzepatide, Boosting Novo Nordisk Shares
Shares of Novo Nordisk (NYSE:NVO) rose over 2% on Monday after new real-world evidence indicated that its obesity treatment Wegovy (semaglutide) 2.4 mg lowered the risk of major cardiovascular events more effectively than Eli Lilly’s (NYSE:LLY) tirzepatide. The data, unveiled at the European Society of Cardiology Congress 2025 in Madrid, came from the STEER study,…
-
Dow Jones, S&P, Nasdaq, Markets brace for U.S. jobs data as tariff dispute continues
U.S. financial markets are closed Monday for Labor Day, but investors are gearing up for a critical week, with the release of fresh labor market data expected to influence Federal Reserve rate-cut expectations. At the same time, the legal battle over Trump-era tariffs is intensifying, with a federal appeals court recently striking down the levies.…
-
Gold Hits Four-Month Peak on Fed Rate-Cut Hopes and Trade Uncertainty
Gold surged to a four-month high in Asian trading on Monday, driven by expectations of a Federal Reserve interest rate cut and heightened safe-haven demand amid U.S. tariff uncertainty and political developments affecting the central bank. Spot gold rose 0.9% to $3,480.56 an ounce, the strongest since mid-April, while December futures climbed 1% to $3,551.82/oz…
-
Asian Currencies, Dollar Hold Steady as Traders Watch Fed and Regional PMIs
Most Asian currencies and the U.S. dollar showed little movement on Monday as traders weighed the odds of a Federal Reserve rate cut later this month, ahead of important U.S. payroll figures scheduled for the end of the week. With U.S. markets closed for a public holiday, investors turned their attention to regional economic data,…
-
Oil Extends Losses as Traders Downplay Sanction Risks on Russian Crude
Oil prices continued to slide in Asian trading on Monday after posting monthly declines in August, as investors appeared to discount the risk of immediate supply disruptions from potential secondary sanctions on Russian oil. Market attention turned instead to Chinese factory data for signs of demand. By 23:01 ET (03:01 GMT), Brent crude for October…
-
Barclays Sees Growing Risks for Chip Equipment Suppliers as Chinese Demand Slows
Chip equipment manufacturers are facing rising challenges in China, where local competitors are gaining traction and demand patterns are beginning to shift, Barclays analysts warned. The bank now projects a 5% decline in China’s wafer front-end (WFE) spending for 2025, followed by a 5% rebound in 2026. However, the outlook appears less favorable for Western…